Your browser doesn't support javascript.
loading
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer.
Gianni, Luca; Colleoni, Marco; Bisagni, Giancarlo; Mansutti, Mauro; Zamagni, Claudio; Del Mastro, Lucia; Zambelli, Stefania; Bianchini, Giampaolo; Frassoldati, Antonio; Maffeis, Ilaria; Valagussa, Pinuccia; Viale, Giuseppe.
Afiliación
  • Gianni L; Fondazione Michelangelo, Milano, Italy. luca.gianni@fondazionemichelangelo.org.
  • Colleoni M; IEO, European Institute of Oncology, IRCCS, Milano, Italy.
  • Bisagni G; Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Mansutti M; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Zamagni C; Addarii Medical Oncology IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.
  • Del Mastro L; IRCCS Ospedale Policlinico San Martino, UO Breast Unit, Genova, Italy.
  • Zambelli S; Università di Genova, Dipartimento di Medicina Interna e Specialità Mediche (Di.M.I.), Genova, Italy.
  • Bianchini G; Department of Medical Oncology, San Raffaele Scientific Institute, Milano, Italy.
  • Frassoldati A; Department of Medical Oncology, San Raffaele Scientific Institute, Milano, Italy.
  • Maffeis I; Department of Oncology, Azienda Ospedaliero Universitaria di Ferrara - Arcispedale Sant'Anna, Ferrara, Italy.
  • Valagussa P; Fondazione Michelangelo, Milano, Italy.
  • Viale G; Fondazione Michelangelo, Milano, Italy.
NPJ Breast Cancer ; 8(1): 1, 2022 Jan 10.
Article en En | MEDLINE | ID: mdl-35013314

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos